ACHIEVE LIFE SCIENCES, INC. (ACHV) › Cash & EquivalentsACHIEVE LIFE SCIENCES, INC. (ACHV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $7.62M2009: $62.05M2010: $23.53M2011: $28.52M2012: $18.07M2013: $14.59M2014: $27.90M2015: $34.31M2016: $15.0K2017: $5.28M2018: $9.52M2019: $16.66M2020: $35.85M2021: $43.02M2022: $24.77M2023: $15.55M2024: $12.75M2025: $20.93M$20.93M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$20.93M+64.1%2024$12.75M-18.0%2023$15.55M-37.2%2022$24.77M-42.4%2021$43.02M+20.0%2020$35.85M+115.2%2019$16.66M+75.1%2018$9.52M+80.1%2017$5.28M+35126.7%2016$15.0K-100.0%2015$34.31M+23.0%2014$27.90M+91.2%2013$14.59M-19.3%2012$18.07M-36.6%2011$28.52M+21.2%2010$23.53M-62.1%2009$62.05M+714.5%2008$7.62M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share